Comparison
Why is Shandong Weigao Group Medical Polymer Co. Ltd. ?
- Healthy long term growth as Net Sales has grown by an annual rate of 27.91%
- Company has very low debt and has enough cash to service the debt requirements
- ROCE(HY) Lowest at 6.69%
- INTEREST COVERAGE RATIO(Q) Lowest at 870.24
- RAW MATERIAL COST(Y) Grown by 7.02% (YoY)
- Over the past year, while the stock has generated a return of -40.21%, its profits have fallen by -60.6%
- Along with generating -40.21% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods
How much should you hold?
- Overall Portfolio exposure to Shandong Weigao Group Medical Polymer Co. Ltd. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Shandong Weigao Group Medical Polymer Co. Ltd. for you?
Medium Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at HKD 10,989.1 MM
Highest at HKD 7,384.01 MM
Lowest at 6.69%
Lowest at 870.24
Grown by 7.02% (YoY
Lowest at HKD 1.78
Highest at HKD 152.26 MM
Lowest at HKD 1,325.03 MM
Lowest at 17.94 %
Lowest at HKD 826.01 MM
Lowest at HKD 661.12 MM
Lowest at HKD 0.15
Here's what is working for Shandong Weigao Group Medical Polymer Co. Ltd.
Net Sales (HKD MM)
Cash and Cash Equivalents
Here's what is not working for Shandong Weigao Group Medical Polymer Co. Ltd.
Operating Profit to Interest
Interest Paid (HKD MM)
Operating Profit (HKD MM)
Operating Profit to Sales
Pre-Tax Profit (HKD MM)
Net Profit (HKD MM)
EPS (HKD)
DPS (HKD)
Raw Material Cost as a percentage of Sales
Non Operating income






